Positron Emission Tomography (PET) scan

PROCEDURE8 trials

Sponsors

AHS Cancer Control Alberta, Stanford University, The Hospital for Sick Children, University of Southern California, National Institute of Mental Health (NIMH)

Conditions

AgingBrain NeoplasmsCancerCognitive Ability, GeneralColorectal NeoplasmsDementiaEpilepsyLung Neoplasms

Phase 1

PET Imaging of Neuroinflammation in Neurodegenerative Diseases Via a Novel Translocator Protein (TSPO) Radioligand

TerminatedNCT03958630

National Institute of Mental Health (NIMH)Dementia

Start: 2019-07-03End: 2023-12-04Updated: 2024-05-01

Phase 2

Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer

CompletedNCT00123760

AHS Cancer Control AlbertaBrain Neoplasms, Colorectal Neoplasms, Lung Neoplasms +2

Start: 2004-02-29End: 2008-12-31Updated: 2016-02-25

Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases

CompletedNCT00375830

Stanford UniversityCancer

Start: 2006-01-31End: 2019-03-14Updated: 2023-12-12

68Ga-DOTA-Bombesin PET/MRI in Imaging Patients With Prostate Cancer

CompletedNCT02440308

Stanford UniversityProstate Carcinoma

Start: 2015-04-30End: 2015-06-30Updated: 2017-04-11

68-Ga-FAPI PET Imaging in Malignancy

WithdrawnNCT04023240

Stanford UniversityCancer

Start: 2023-07-31End: 2023-12-14Updated: 2024-08-12

Phase 3

Cerebral Metabolic Changes Associated With Thalamic Stimulation

TerminatedNCT01141764

The Hospital for Sick ChildrenEpilepsy

Start: 2010-03-31End: 2014-02-28Updated: 2014-11-21

Unknown Phase

Lifestyle Enriching Activities for Research in Neuroscience Intervention Trial: LEARNit Study

CompletedNCT02726906

University of Southern CaliforniaAging, Cognitive Ability, General

Start: 2016-08-21End: 2022-07-15Updated: 2024-10-02

Use of 68Ga-dotatate PET Scan in Neuroendocrine Carcinoma of the GI Tract

CompletedNCT04069299

H. Lee Moffitt Cancer Center and Research InstituteNeuroendocrine Carcinoma

Start: 2019-09-25End: 2025-06-02Updated: 2026-03-31

Related Papers

<sup>68</sup>Ga-DOTA-Bombesin (<sup>68</sup>Ga-RM2 or <sup>68</sup>Ga-Bombesin) PET versus <sup>68</sup>Ga-PSMA PET: A pilot prospective evaluation in patients with biochemical recurrence of prostate cancer.

Journal of Clinical Oncology2016-01-102 citations